相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407)
Masato Ozaka et al.
EUROPEAN JOURNAL OF CANCER (2023)
Efficacy and Safety of the Combination of Nano-Liposomal Irinotecan and 5-Fluorouracil/L-Leucovorin in Unresectable Advanced Pancreatic Cancer: A Real-World Study
Hidetoshi Yasuoka et al.
ONCOLOGY (2022)
Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3)
Se-Il Go et al.
EUROPEAN JOURNAL OF CANCER (2021)
The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Cancer
Ryoji Takada et al.
CANCERS (2021)
Efficacy and safety of modified fluorouracil/leucovorin plus irinotecan and oxaliplatin (mFOLFIRINOX) compared with S-1 as second-line chemotherapy in metastatic pancreatic cancer
Kenji Ikezawa et al.
JGH OPEN (2021)
Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines
Takuji Okusaka et al.
JOURNAL OF GASTROENTEROLOGY (2020)
nal-IRI+5-FU/LV versus 5-FU/LV in post-gemcitabine metastatic pancreatic cancer: Randomized phase 2 trial in Japanese patients
Makoto Ueno et al.
CANCER MEDICINE (2020)
Maximising Capacity and Saving Cost in an Outpatient Chemotherapy Centre during a Pandemic: A Quality Improvement Project
Ednajoy Ngo et al.
BLOOD (2020)
Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
Michele Stanchina et al.
CANCERS (2020)
Improvement in the survival of patients with stage IV non-small-cell lung cancer: Experience in a single institutional 1995-2017
Natsuki Takano et al.
LUNG CANCER (2019)
A phase II study of modified FOLFIRINOX for chemotherapy-na < ve patients with metastatic pancreatic cancer
Masato Ozaka et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Alternative Outpatient Chemotherapy Scheduling Method to Improve Patient Service Quality and Nurse Satisfaction
Yu-Li Huang et al.
JOURNAL OF ONCOLOGY PRACTICE (2018)
Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer
Hideki Ueno et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
Andrea Wang-Gillam et al.
LANCET (2016)
Phase II study of FOLFIRINOX for chemotherapy-naive Japanese patients with metastatic pancreatic cancer
Takuji Okusaka et al.
CANCER SCIENCE (2014)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Levoleucovorin as Replacement for Leucovorin in Cancer Treatment
Victor Tuan Giam Chuang et al.
ANNALS OF PHARMACOTHERAPY (2012)
Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group
Uwe Pelzer et al.
EUROPEAN JOURNAL OF CANCER (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Is Levoleucovorin an Alternative to Racemic Leucovorin? A Literature Review
Philip A. Kovoor et al.
CLINICAL COLORECTAL CANCER (2009)
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:: A randomized GERCOR study
C Tournigand et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
分享论文
